NASHUA, N.H., July 27, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the second quarter ended June 30, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on August 10, 2022.
August 10, 2022 at 4:30 PM ET
Domestic: 888-506-0062
International: 973-528-0011
Conference ID: 718241
Webcast: https://www.webcaster4.com/Webcast/Page/2879/46166
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.
Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com
Investor Inquiries:
iCAD Investor Relations
ir@icadmed.com
RONKONKOMA, N.Y.--(BUSINESS WIRE)--#biopharma--Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical…
RONKONKOMA, N.Y.--(BUSINESS WIRE)--#biopharma--Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical…
GE HealthCare and MediView XR, Inc. announce the first installation and clinical use of augmented…
ATLANTA, June 20, 2024 /PRNewswire/ -- Rower Consulting, a trailblazer in cutting-edge analytics and artificial…
Celebrated as a Bold Leader, Lytle, Founder, Chairman and CEO of Equality Health, Recognized for…
Fraud and abuse in lab testing linked to looser telehealth regulations. TAMPA, Fla., June 20,…